Cytomx Therapeutics Inc (CTMX)

11:32 AM

CytomX Therapeutics: Cashed Up With Catalysts Ahead (NASDAQ:CTMX) - Seeking Alpha

11:32 AM

May 22, 2026

Wolfe Research Initiates Coverage of CytomX Therapeutics (CTMX) with Outperform - Insider Monkey

May 22, 2026

May 21, 2026

CytomX Therapeutics to Present at Upcoming June Investor Conferences - The Manila Times

May 21, 2026

May 21, 2026

CytomX Therapeutics in June investor events at Jefferies, Goldman Sachs - Stock Titan

May 21, 2026

May 20, 2026

CTMX Stock Price, Quote & Chart | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - ChartMill

May 20, 2026

May 19, 2026

Wolfe Research initiates CytomX stock with outperform rating By Investing.com - Investing.com Australia

May 19, 2026

May 19, 2026

Wolfe Research Initiates CytomX Therapeutics With Outperform Rating - Moomoo

May 19, 2026

May 19, 2026

Wolfe Research initiates CytomX stock with outperform rating - Investing.com

May 19, 2026

May 18, 2026

CytomX appoints Mamata Gokhale as regulatory affairs head By Investing.com - Investing.com Australia

May 18, 2026

May 18, 2026

CytomX appoints Mamata Gokhale as regulatory affairs head - Investing.com

May 18, 2026

May 18, 2026

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory ... - Caledonian Record

May 18, 2026

May 18, 2026

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs - Yahoo Finance

May 18, 2026

May 17, 2026

Cantor Fitzgerald Initiates Coverage of CytomX Therapeutics (CTMX) with Overweight Recommendation - MSN

May 17, 2026

May 15, 2026

Seven Fleet group beneficially owns 1,085,398 CTMX shares (NASDAQ: CTMX) - Stock Titan

May 15, 2026

May 15, 2026

Longitude funds, managers report sizable CTMX stakes (CTMX) — 7.0% by principals - Stock Titan

May 15, 2026

May 15, 2026

Venrock group files Amendment reporting 9.98M CTMX shares (NASDAQ: CTMX) - Stock Titan

May 15, 2026

May 15, 2026

Kynam Capital (CTMX) discloses 15.0M-share, 6.90% stake in CytomX (Schedule 13G/A) - Stock Titan

May 15, 2026

May 15, 2026

Perceptive (CTMX) reports 10,098,824 shares, a 4.6% stake - Stock Titan

May 15, 2026

May 15, 2026

CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar - TipRanks

May 15, 2026

May 14, 2026

CytomX Therapeutics stock (US23284F1057): Recent price volatility draws attention - AD HOC NEWS

May 14, 2026

May 14, 2026

Brokers Are Upgrading Their Views On CytomX Therapeutics, Inc. (NASDAQ:CTMX) With These New Forecasts - 富途牛牛

May 14, 2026

May 13, 2026

HC Wainwright Analysts Increase Earnings Estimates for CTMX - MarketBeat

May 13, 2026

May 13, 2026

Broker Revenue Forecasts For CytomX Therapeutics, Inc. (NASDAQ:CTMX) Are Surging Higher - simplywall.st

May 13, 2026

May 13, 2026

New Forecasts: Here's What Analysts Think The Future Holds For CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Yahoo Finance

May 13, 2026

May 11, 2026

Earnings call transcript: CytomX Therapeutics Q1 2026 beats EPS forecast - Investing.com UK

May 11, 2026

May 11, 2026

Earnings call transcript: CytomX Therapeutics Q1 2026 beats EPS forecast By Investing.com - Investing.com Nigeria

May 11, 2026

May 11, 2026

CTMX Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus

May 11, 2026

May 11, 2026

H.C. Wainwright cuts CytomX stock price target on trial data By Investing.com - Investing.com South Africa

May 11, 2026

May 11, 2026

Earnings Update: CytomX Therapeutics, Inc. (NASDAQ:CTMX) Just Reported And Analysts Are Boosting Their Estimates - 富途牛牛

May 11, 2026

May 11, 2026

Earnings Beat: CytomX Therapeutics, Inc. (NASDAQ:CTMX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance

May 11, 2026

May 11, 2026

H.C. Wainwright cuts CytomX stock price target on trial data - Investing.com

May 11, 2026

May 09, 2026

CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability - TipRanks

May 09, 2026

May 08, 2026

CytomX Earnings Call Highlights Varseta-M Momentum - TipRanks

May 08, 2026

May 08, 2026

CytomX (CTMX) Q1 2026 Earnings Transcript - AOL.com

May 08, 2026

May 08, 2026

CytomX Q1 2026 slides: Varseta-M shows 32% response in CRC trial - Investing.com Canada

May 08, 2026

May 08, 2026

Earnings call transcript: CytomX Therapeutics beats Q1 2026 forecasts - Investing.com UK

May 08, 2026

May 08, 2026

CytomX Therapeutics (CTMX) Prepares for Transformational Year in 2026 - GuruFocus

May 08, 2026

May 07, 2026

Earnings call transcript: CytomX Therapeutics beats Q1 2026 forecasts By Investing.com - Investing.com India

May 07, 2026

May 07, 2026

CytomX Therapeutics (CTMX) reports Q1 loss, beats revenue estimates - MSN

May 07, 2026

May 07, 2026

CytomX Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2026

May 07, 2026

CytomX Therapeutics Q1 Earnings Call Highlights - Yahoo Finance

May 07, 2026

May 07, 2026

CytomX Therapeutics (NASDAQ:CTMX) Q1 2026 Revenue Beat Sparks Cautious Market Rally - ChartMill

May 07, 2026

May 07, 2026

CytomX Therapeutics (CTMX) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance

May 07, 2026

May 07, 2026

CytomX Therapeutics: Q1 Earnings Snapshot - marketscreener.com

May 07, 2026

May 07, 2026

Earnings Flash (CTMX) CytomX Therapeutics, Inc. Reports Q1 Revenue $10.3M, vs. FactSet Est of $4.7M - marketscreener.com

May 07, 2026